ANEBULO PHARMAC INC by Anebulo Pharmaceuticals Inc Financials - Benzinga

ANEBULO PHARMAC INC by Anebulo Pharmaceuticals Inc

ANEBOTCEM

Trade with Public

Trade with Public

$0.3600

-0.0711-16.49%

At close: Feb 26, 4:00 PM EST

Overview News Earnings Forecast Price TargetsFinancialsSentiment Ownership Compare

ANEBULO PHARMAC INC by Anebulo Pharmaceuticals Inc Financials

ANEBULO PHARMAC INC by Anebulo Pharmaceuticals Inc (ANEB) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Anebulo Pharmaceuticals Q2 EPS $(0.05) Beats $(0.13) Estimate

Anebulo Pharmaceuticals (NASDAQ:ANEB) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.13) by 61.54 percent. This is a 44.44 percent increase over losses of $(0.09) per

Benzinga Newsdesk

US Stocks Higher; Nasdaq Surges Over 100 Points

Avi Kapoor

PRO
Anebulo Pharmaceuticals Q1 EPS $(0.05) Beats $(0.12) Estimate

Anebulo Pharmaceuticals (NASDAQ:ANEB) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.12) by 58.33 percent. This is a 37.5 percent increase over losses of $(0.08) per share

Benzinga Newsdesk

PRO
Anebulo Pharmaceuticals Q4 EPS $(0.05) Beats $(0.08) Estimate

Benzinga Newsdesk

Crude Oil Falls; Thermo Fisher Scientific Earnings Top Views

Avi Kapoor

Dow Surges Over 200 Points; AT&T Posts Upbeat Earnings

Avi Kapoor